Breakthrough from Weill Cornell Medicine

Researchers from Weill Cornell Medicine in New York have figured out how to grow pulmonary neuroendocrine cells (PNECs) from human embryonic stem cells.  This gives new insight into two genes that are commonly mutated in small cell lung cancer (SCLC).

The Weill Cornell team was co-led by Nobel Prize winner and former National Cancer Institute director Harold Varmus M.D.

Click here to read full article on Fierce Biotech website

 

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

Expressions of interest open for ANZSNM nurse and allied health workshop in Canberra

NECA partners with Oncidium ahead of World Radiotheranostics Day 2026

Bringing Together Experts to Improve NET Patient Care: NECA at the 5th NET Preceptorship

NECA at ENETS 2025: Advancing NET Care on the Global Stage

Our NET Nurses are here to help support you from diagnosis to treatment, and living well with NETs.

Free and confidential, our NET nurses are available Monday – Friday, 9am – 5pm (AEDT).